-
TTOO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
T2 Biosystems (TTOO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.60 mm | 2.60 mm | 2.60 mm | 2.60 mm | 2.60 mm | 2.60 mm |
Cash burn (monthly) | 733.33 k | 1.81 mm | 3.39 mm | 3.47 mm | 2.08 mm | 3.05 mm |
Cash used (since last report) | 3.13 mm | 7.73 mm | 14.46 mm | 14.82 mm | 8.90 mm | 13.02 mm |
Cash remaining | -531.59 k | -5.13 mm | -11.86 mm | -12.22 mm | -6.30 mm | -10.42 mm |
Runway (months of cash) | -0.7 | -2.8 | -3.5 | -3.5 | -3.0 | -3.4 |
13F holders | Current |
---|---|
Total holders | 28 |
Opened positions | 3 |
Closed positions | 3 |
Increased positions | 5 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 4.28 bn |
Total shares | 24.18 mm |
Total puts | 0.00 |
Total calls | 82.30 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
CR | 10.68 mm | $34.06 mm |
Goldman Sachs & Co | 4.36 mm | $5.41 mm |
Aisling Capital Iii | 2.83 mm | $0.00 |
Flagship Ventures Fund 2004 L P | 1.63 mm | $0.00 |
Armistice Capital | 1.40 mm | $2.75 bn |
Lind Global Fund II | 1.02 mm | $815.00 k |
New Dimensions Trading | 755.00 k | $2.37 mm |
Jacob Safier | 755.00 k | $2.37 mm |
Vanguard | 390.37 k | $769.03 mm |
Geode Capital Management | 90.88 k | $179.15 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Nov 24 | John M Sprague | RSU Common Stock | Grant | Acquire A | No | No | 0 | 180,000 | 0.00 | 180,000 |
4 Nov 24 | John M Sprague | RSU Common Stock | Grant | Acquire A | No | No | 0 | 180,000 | 0.00 | 180,000 |
4 Nov 24 | David B Elsbree | RSU Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 25,000 |
4 Nov 24 | John J Sperzel III | RSU Common Stock | Grant | Acquire A | No | No | 0 | 490,000 | 0.00 | 490,000 |
4 Nov 24 | John J Sperzel III | RSU Common Stock | Grant | Acquire A | No | No | 0 | 490,000 | 0.00 | 490,000 |
4 Nov 24 | Robin Toft | RSU Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 25,000 |
4 Nov 24 | Ninfa Saunders | RSU Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 25,000 |